Medium-sized drug makers go for duel with multinational giant

Competition is about to heat up in the Korean antihypertensive market dominated by Pfizer Korea's Norvasc (amlodipine besylate) as a growing number of medium-sized pharmaceutical firms are ready to enter the local market.

Hanlim Pharm announced on August 7 that it would step into the antihypertensive market by launching a chiral amlodipine compound (S-amlodipine) on November through completi...